Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium citrate and citric acid |
Is a |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
Sodium citrate mixture BPC |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
dinatriumcitrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
nalidixinsyre + natriumcitrat 660 mg brev brusegranulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
Sodium citrate 4 g granules for oral solution sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
nalidixinsyre + natriumcitrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitratdihydrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
citronsyremonohydrat 334 mg + natriumcitrat 500 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
citronsyre 640 mg + natriumcitrat 490 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
citronsyremonohydrat 334 mg + natriumcitratdihydrat 500 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|
citronsyre + monohydrat + kaliumcitrat 550 mg + natriumcitrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disodium citrate (substance) |
Inferred relationship |
Some |
|